You are here

NIH no longer recommends Eli Lilly or Regeneron monoclonal antibodies in its Covid-19 treatment guidelines

Primary tabs

NIH no longer recommends Eli Lilly or Regeneron monoclonal antibodies in its Covid-19 treatment guidelines

Thu, 2022-01-20 11:14 — mike kraft

NIH no longer recommends Eli Lilly or Regeneron monoclonal antibodies in its Covid-19 treatment guidelines The National Institutes of Health Covid-19 treatment guidelines no longer recommend the use of two authorized monoclonal antibody treatments for patients with mild to moderate Covid-19 due to their diminished effectiveness against the Omicron variant. By <a href="/profiles/aditi-sandal">Aditi Sangal</a> and <a href="/profiles/adrienne-vogt">Adrienne Vogt</a>, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

Medical - global

- Private group -

Log in or register to post comments

Workflow history

Revision ID	Field name	Date	Old state	New state name	By	Commentaire	Operations
			No state	No state

Page loaded in 0.463 seconds.